1. Home
  2. EHAB vs MRVI Comparison

EHAB vs MRVI Comparison

Compare EHAB & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enhabit Inc.

EHAB

Enhabit Inc.

HOLD

Current Price

$13.62

Market Cap

690.3M

Sector

Health Care

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.08

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHAB
MRVI
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
690.3M
472.8M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
EHAB
MRVI
Price
$13.62
$3.08
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$13.84
$4.00
AVG Volume (30 Days)
2.3M
1.2M
Earning Date
01-01-0001
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
97.11
14.29
EPS
N/A
N/A
Revenue
$1,060,000,000.00
$185,743,000.00
Revenue This Year
$6.23
$11.80
Revenue Next Year
$4.35
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
2.44
N/A
52 Week Low
$6.47
$1.67
52 Week High
$13.66
$4.11

Technical Indicators

Market Signals
Indicator
EHAB
MRVI
Relative Strength Index (RSI) 79.70 38.72
Support Level $10.79 $2.88
Resistance Level $13.64 $3.99
Average True Range (ATR) 0.03 0.21
MACD -0.06 -0.02
Stochastic Oscillator 50.00 2.91

Price Performance

Historical Comparison
EHAB
MRVI

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: